CBARX
Price
$46.08
Change
+$0.27 (+0.59%)
Updated
Jan 17 closing price
Net Assets
1.38B
CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
240.18B
Ad is loading...

CBARX vs CLBCX

Header iconCBARX vs CLBCX Comparison
Open Charts CBARX vs CLBCXBanner chart's image
Calvert Balanced R6
Price$46.08
Change+$0.27 (+0.59%)
VolumeN/A
Net Assets1.38B
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets240.18B
CBARX vs CLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBARX vs. CLBCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBARX is a Hold and CLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 240B vs. CBARX (1.38B). CBARX pays higher dividends than CLBCX: CBARX (2.44) vs CLBCX (1.52). CBARX was incepted earlier than CLBCX: CBARX (6 years) vs CLBCX (23 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. CBARX (106.00). CLBCX has a lower initial minimum investment than CBARX: CLBCX (250) vs CBARX (5000000). CBARX annual gain was more profitable for investors over the last year : 15.76 vs. CLBCX (11.42). CBARX return over 5 years is better than : 36.83 vs. CLBCX (26.62).
CBARXCLBCXCBARX / CLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years23 years-
Gain YTD1.1861.89463%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B240B1%
Annual Yield % from dividends2.441.52161%
Returns for 1 year15.7611.42138%
Returns for 3 years19.1411.24170%
Returns for 5 years36.8326.62138%
Returns for 10 yearsN/A56.78-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin